This company listing is no longer active
Resumen de acción 9KI
Igeamed S.p.A. provides consulting, engineering, training, and medical services.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Igeamed S.p.A.
Historial de precios y rendimiento
Historical stock prices | |
---|---|
Current Share Price | €2.38 |
52 Week High | €2.48 |
52 Week Low | €2.38 |
Beta | 0.12 |
1 Month Change | -4.03% |
3 Month Change | -4.03% |
1 Year Change | -4.03% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 11.22% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
9KI | DE Professional Services | Mercado DE | |
---|---|---|---|
7D | -4.0% | 1.0% | -1.0% |
1Y | -4.0% | -25.4% | 3.0% |
Rentabilidad vs. Industria: 9KI underperformed the German Professional Services industry which returned 14.1% over the past year.
Rentabilidad vs. Mercado: 9KI underperformed the German Market which returned 7.4% over the past year.
Volatilidad de los precios
9KI volatility | |
---|---|
9KI Average Weekly Movement | 1.2% |
Professional Services Industry Average Movement | 4.5% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 10.4% |
10% least volatile stocks in DE Market | 2.6% |
Precio estable de las acciones: 9KI has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: 9KI's weekly volatility (1%) has been stable over the past year.
Acerca de la empresa
Fundada | Empleados | CEO | Página web |
---|---|---|---|
1979 | 26 | Michele Casciani | www.igeam.it |
Resumen de fundamentos de Igeamed S.p.A.
Estadísticas fundamentales de 9KI | |
---|---|
Capitalización bursátil | €5.65m |
Beneficios(TTM) | -€21.93k |
Ingresos (TTM) | €7.69m |
0.7x
Ratio precio-ventas (PS)-245.1x
Ratio precio-beneficio (PE)¿Está 9KI sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
Cuenta de resultados (TTM) de 9KI | |
---|---|
Ingresos | €7.69m |
Coste de los ingresos | €7.12m |
Beneficio bruto | €572.09k |
Otros gastos | €594.02k |
Beneficios | -€21.93k |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
Beneficios por acción (BPA) | -0.0097 |
Margen bruto | 7.44% |
Margen de beneficio neto | -0.29% |
Ratio deuda/patrimonio | 56.3% |
¿Cómo se ha desempeñado 9KI a largo plazo?
Ver rendimiento histórico y comparativa